Seasonal Influenza Vaccination Resources for Health Professionals
Note: “ACIP Recommendations for the Use of Quadrivalent Live Attenuated Influenza Vaccine (LAIV4) — United States, 2018–19 Influenza Season” appeared in an MMWR report on June 8, 2018. The full ACIP recommendations on the Prevention and Control of Seasonal Influenza with Vaccines will be published later this summer. Content throughout the rest of the influenza web site will be updated over the coming weeks.
Information for the 2017-18 Influenza Season
- Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season
- TABLE: Influenza vaccines — United States, 2017–18 influenza season
- FIGURE: Influenza vaccine dosing algorithm for children aged 6 months through 8 years — Advisory Committee on Immunization Practices, United States, 2017–18 influenza seasons
- FIGURE: Recommendations regarding influenza vaccination of persons who report allergy to eggs
Dosage, Administration, Storage & Handling
- Dosage & Administration (Q&A)
- Large-Scale Influenza Vaccination Clinic Planning
- Packing, Shipping, Handling, & Storing Influenza Vaccine [610 KB, 14 Pages], guidelines for packing, shipping, handling, & storage of vaccine; vaccines are listed alphabetically.
- Influenza Vaccine Availability Tracking System (IVATS) , a resource to enable healthcare providers to find influenza vaccine to purchase.
Summary for Health Care Professionals
Supply & Distribution
Effectiveness & Safety
- Flu Vaccination & Possible Safety Signal
- Seasonal Influenza Vaccine Effectiveness, 2005-2017
- Flu Vaccine Effectiveness (Q&A for Health Professionals)
- Vaccine Adverse Event Reporting System (VAERS), also available by telephone at 1–800–822–7967
The recommendations for vaccination of people with egg allergies have not changed since last season (2016-2017).
People with egg allergies can receive any licensed, recommended age-appropriate influenza vaccine and no longer have to be monitored for 30 minutes after receiving the vaccine. People who have severe egg allergies should be vaccinated in a medical setting and be supervised by a health care provider who is able to recognize and manage severe allergic conditions.
- Page last reviewed: June 14, 2018
- Page last updated: June 14, 2018
- Content source:
- Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)
- Page maintained by: Office of the Associate Director for Communication, Digital Media Branch, Division of Public Affairs